An Australian health care company will use the personal genetic signature of patients with type 2 diabetes to try to prevent them having complications such as heart disease.
|Professor Grant Morahan|
Genome-based healthcare company Fitgenes will use WA-invented genetic profiling technology to predict the specific health complications people with diabetes are likely to develop.
The technology was discovered by Professor Grant Morahan from the Harry Perkins Institute of Medical Research to identify lifestyle interventions such as diet that could help patients.
Professor Morahan, who will talk about the advance in Perth for World Diabetes Day next month, said it was a major step forward.
“We are very excited that our understanding of the specific genetic signature of a person with type 2 diabetes is now being taken from the laboratory and into a patient care setting,” he said.
“People with type 2 diabetes who are more likely to develop heart disease can receive nutrition, exercise and lifestyle advice that is tailored to their own genetic make-up.”
Professor Morahan said researchers were partnering with Fitgenes to use the same type of knowledge for other diseases they were investigating.
Diabetes Research WA Executive Director Sherl Westlund said it was taking scientific discoveries from the bench to the bedside.
“We’re excited about the potential this partnership has to improve the lives of those with type 2 diabetes,” she said.
Professor Morahan will discuss the advance on November 13, the eve of World Diabetes Day.